Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last ¥6,170 JPY
Change Today -130.00 / -2.06%
Volume 201.0K
4927 On Other Exchanges
Symbol
Exchange
Tokyo
Berlin
OTC US
As of 2:00 AM 03/27/15 All times are local (Market data is delayed by at least 15 minutes).

pola orbis holdings inc (4927) Snapshot

Open
¥6,290
Previous Close
¥6,300
Day High
¥6,320
Day Low
¥6,120
52 Week High
03/25/15 - ¥6,440
52 Week Low
04/9/14 - ¥3,612
Market Cap
353.4B
Average Volume 10 Days
230.8K
EPS TTM
¥187.80
Shares Outstanding
57.3M
EX-Date
06/26/15
P/E TM
32.9x
Dividend
¥150.00
Dividend Yield
3.03%
Current Stock Chart for POLA ORBIS HOLDINGS INC (4927)

Related News

No related news articles were found.

pola orbis holdings inc (4927) Related Businessweek News

No Related Businessweek News Found

pola orbis holdings inc (4927) Details

POLA Orbis Holdings, Inc., through its subsidiaries, is engaged in the development, manufacture, and sale of cosmetics, fashion products, and pharmaceuticals in Japan and internationally. The company’s Beauty Care segment offers cosmetics; skincare products; health foods; and fashion items, such as women’s underwear, women’s apparel, and jewelry under the POLA, ORBIS, pdc, FUTURE LABO, ORLANE JAPON, decencia, THREE, Jurlique, and H2O PLUS brand names, as well as provides cosmetics, consulting, and facial esthetic treatment services. Its Real Estate segment is involved in the leasing of office buildings and residential properties. The company’s Others segment develops and sells drugs comprising Lulicon, an antifungal agent for topical application; and DIVIGEL, a treatment for menopausal symptoms. POLA Orbis Holdings, Inc. sells its products through department, directly operated retail, specialty cosmetics, and drug stores, as well as supermarkets, general retail outlets, shopping malls, TV shopping channels, door-to-door sales, and mail-order sales. The company was founded in 1929 and is headquartered in Tokyo, Japan.

Founded in 1929

pola orbis holdings inc (4927) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

pola orbis holdings inc (4927) Key Developments

POLA Orbis Holdings, Inc. Presents at Credit Suisse 18th Annual Asian Investment Conference 2015, Mar-23-2015

POLA Orbis Holdings, Inc. Presents at Credit Suisse 18th Annual Asian Investment Conference 2015, Mar-23-2015 . Venue: Conrad Hotel, Pacific Place, 88 Queensway, Hong Kong, Hong Kong.

POLA Orbis Holdings, Inc., Annual General Meeting, Mar 26, 2015

POLA Orbis Holdings, Inc., Annual General Meeting, Mar 26, 2015.

POLA Orbis Holdings, Inc. - Special Call

POLA Orbis Holdings, Inc. - Special Call

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4927:JP ¥6,170.00 JPY -130.00

4927 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4927.
View Industry Companies
 

Industry Analysis

4927

Industry Average

Valuation 4927 Industry Range
Price/Earnings 33.6x
Price/Sales 1.8x
Price/Book 1.9x
Price/Cash Flow 22.3x
TEV/Sales 1.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact POLA ORBIS HOLDINGS INC, please visit www.po-holdings.co.jp. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.